Telix Pharmaceuticals Lim...

PNK: TLPPF · Real-Time Price · USD
16.54
-0.21 (-1.25%)
At close: May 23, 2025, 3:05 PM

Revenue by Geography

Period Ending Dec 31, 2024
Australia Revenue 1.22M
Australia Revenue Growth n/a
Belgium Revenue 546K
Belgium Revenue Growth n/a
Canada Revenue 2.54M
Canada Revenue Growth n/a
United States Revenue 762.31M
United States Revenue Growth n/a

Operating Expense Breakdown

Period Ending Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021 Dec 31, 2020 Jun 30, 2020 Dec 31, 2019 Jun 30, 2019 Dec 31, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Jun 30, 2017 Mar 31, 2017 Jan 31, 2017
Selling, General, and Administrative Revenue 64.25M 30.07M 105.5M 28.93M 21.58M 23.08M 10.59M 6.75M 6.41M 2.88M 5.04M 2.17M 5.14M 4M 2.27M 2.77M 774.63K 667.82K 667.82K
Selling, General, and Administrative Revenue Growth +113.69% -71.50% +264.73% +34.03% -6.49% +117.87% +56.84% +5.35% +122.60% -42.91% +131.95% -57.69% +28.39% +76.39% -18.00% +257.29% +15.99% 0.00% n/a
Research and Development Revenue 45.78M 25.05M 98.4M 30.45M 33.01M 24.84M 20.46M 13.67M 14.48M 8.61M 13.32M 7.84M 12.24M 6.45M 4.67M 2.18M 801.91K 744.26K 744.26K
Research and Development Revenue Growth +82.80% -74.55% +223.17% -7.78% +32.89% +21.39% +49.71% -5.59% +68.27% -35.41% +69.93% -35.94% +89.63% +38.11% +114.84% +171.25% +7.75% 0.00% n/a